These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2411117)

  • 1. [Conservative treatment of benign prostatic hypertrophy--clinical effects of increased administration of Hachimijiogan and the relation between these effects and the "Sho" of Chinese medicine].
    Yachiku S; Kaneko S; Matsuura T; Akiyama T; Kurita T
    Hinyokika Kiyo; 1985 Mar; 31(3):545-51. PubMed ID: 2411117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Conservative treatment of benign prostatic hypertrophy: reevaluation of the effect of eviprostat by subjective symptoms and uroflowmetry].
    Matsuura T; Wakabayashi A; Kaneko S; Kurita T
    Hinyokika Kiyo; 1986 Jun; 32(6):903-6. PubMed ID: 2429533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of Chinese drug therapy on the patients with male infertility. 1. Concomitant administration of ninjinto and hachimijiogan on patients with male infertility].
    Nishizawa Y
    Hinyokika Kiyo; 1984 Feb; 30(2):265-73. PubMed ID: 6741762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of the long-term treatment with chlormadinone acetate in patients with benign prostatic hypertrophy].
    Kogawa T; Yanagiya H; Takashima T; Higashino I; Kudo T; Suzuki T; Mikuni T; Kido K; Tsukui A; Yagihashi Y
    Hinyokika Kiyo; 1993 Mar; 39(3):281-7. PubMed ID: 7685143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic effect of Robaveron tablet (KN-7) on urinary disturbance by benign prostatic hypertrophy].
    Sonoda T; Endo H; Maru A; Sasaki K; Kuroda K; Takamura T; Inada F; Rokuzyo M; Ohori T; Kubo T
    Hinyokika Kiyo; 1985 Mar; 31(3):553-62. PubMed ID: 2411118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical effects of Tsumura No. 111 Seishin-rensi-in on irregular complaints of the urinary tract].
    Ohno J; Sonoda T; Ishibashi A; Kitagawa R; Takeuchi Z; Machida T; Katayama T
    Hinyokika Kiyo; 1986 Jul; 32(7):1069-73. PubMed ID: 3776769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the effectiveness of prazosin in conservative treatment of benign prostatic hypertrophy].
    Górecki R; Krzeski T; Wasik J; Borówka A
    Pol Tyg Lek; 1992 Jun 15-29; 47(24-26):549-51. PubMed ID: 1282713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study of allylestrenol (Perselin) on patients with prostatic hypertrophy].
    Fukuoka H; Ishibashi Y; Shiba T; Tuchiya F; Sakanishi S
    Hinyokika Kiyo; 1993 Jul; 39(7):679-83. PubMed ID: 7689782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical effects of allylestrenol on prostatic hypertrophy].
    Kohri K; Kurita T; Iguchi M; Kataoka K
    Hinyokika Kiyo; 1986 Mar; 32(3):486-92. PubMed ID: 2425611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical effects of allylestrenol on patients with benign prostatic hyperplasia (BPH) evaluated with criteria for treatment efficacy in BPH].
    Noguchi K; Takeda M; Hosaka M; Kubota Y
    Hinyokika Kiyo; 2002 May; 48(5):269-73. PubMed ID: 12094708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of cernilton in the treatment of the benign prostatic hypertrophy].
    Horii A; Iwai S; Maekawa M; Tsujita M
    Hinyokika Kiyo; 1985 Apr; 31(4):739-46. PubMed ID: 2412423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment of voiding disorders and conservative pharmacological treatment of benign prostatic hypertrophy].
    Park YC; Takada M; Sugiyama T; Matsuura T; Kaneko S; Akiyama T; Kurita T; Yachiku S
    Hinyokika Kiyo; 1986 Nov; 32(11):1576-83. PubMed ID: 2435121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of desmopressin as an alternative in the treatment of nycturia in patients with benign prostatic hyperplasia (BPH)].
    Granados Loarca EA; Garat Barredo JM; Villavicencio Mavrich H
    Actas Urol Esp; 1999 Jan; 23(1):56-9. PubMed ID: 10089634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical effect of allylestrenol on benign prostatic hypertrophy].
    Tajima A; Aso Y; Ushiyama T; Hata M; Kambayashi T; Ohmi Y; Masuda H; Nakahara M; Kitagawa M; Suzuki A
    Hinyokika Kiyo; 1986 Mar; 32(3):477-85. PubMed ID: 2425610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of moxisylyte hydrochloride in the symptomatic treatment of benign prostatic hyperplasia].
    Izumi H; Kudo S; Fuino A; Yokoyama E; Ishibashi A
    Hinyokika Kiyo; 1989 Mar; 35(3):541-9. PubMed ID: 2472054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical effects of goshajinkigan for male infertility].
    Takayama H; Konishi T; Kounami T; Wakabayashi Y; Watanabe J; Hayashida H; Tomoyoshi T
    Hinyokika Kiyo; 1984 Nov; 30(11):1685-9. PubMed ID: 6528851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of allylestrenol (Org AL-25) on patients with prostatic hypertrophy--transrectal ultrasonography and urodynamic examination].
    Ohyama M; Tanifuji T; Haraguchi C; Fujii N; Higaki Y; Yoshida H; Imamura K
    Hinyokika Kiyo; 1986 Apr; 32(4):649-59. PubMed ID: 2426933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [System review of the Chinese medicine bushenhuoxue for treating benign prostatic hyperplasia].
    Wang L; Zhou S; Shao J; Zhang S
    Zhonghua Nan Ke Xue; 2004 Oct; 10(10):785-9. PubMed ID: 15562796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical efficacy of oxendolene (antiandrogen) and bunazosin hydrochloride (alpha-adrenergic blocker) in the treatment of prostatism--comparative study of oxendolone, bunazocin hydrochloride and their combination].
    Kumamoto Y; Tsukamoto T; Takagi Y; Furuya S; Yokoyama E; Takatsuka K; Tamiya T; Miyamoto S; Aoyama T; Honma A
    Hinyokika Kiyo; 1987 Nov; 33(11):1921-41. PubMed ID: 2451412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of long-term administration of finasteride (MK-906), an inhibitor of 5 alpha-reductase, in patients with benign prostatic hyperplasia.
    Yoshida O; Oishi K; Okada Y; Mizutani Y; Itokawa Y; Tomoyoshi T; Okada K; Komatz Y; Matsuda T; Takeuchi H
    Hinyokika Kiyo; 1996 Apr; 42(4):323-31. PubMed ID: 8693970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.